Key result
Catheter ablation effectively reduces ventricular arrhythmia burden in cardiac sarcoidosis within a multifaceted treatment strategy.
Why the study?
The management of sustained ventricular arrhythmias presents unique challenges in patients with cardiac sarcoidosis and other arrhythmogenic inflammatory cardiomyopathies.
This review highlights catheter ablation as an effective strategy for reducing ventricular arrhythmia burden in patients with cardiac sarcoidosis when combined with medical therapy.
Answers are grounded in this paper and cite their sources.
Supports ablation consideration in refractory cardiac sarcoidosis; leaves open need for prospective RCTs.
Ventricular arrhythmias are a common clinical manifestation in patients with cardiac sarcoidosis (CS) and other arrhythmogenic inflammatory cardiomyopathies (AIC). The management of sustained ventricular arrhythmias in these patients presents unique challenges. Current therapies include immunosuppressive, antiarrhythmic agents, and catheter ablation. Significant progress has been made in deciphering the importance of patient selection for ablation, systematic preablation evaluation, and optimal ablation timing, as well as ablation approaches and techniques. In this overview, we discuss the evaluation and management of ventricular arrhythmias in patients with CS, focusing on catheter ablation, which has evolved into an effective approach in reducing the burden of ventricular arrhythmias in these patients in the context of multifaceted treatment along with medical therapies.
No takes yet. Share an insight, caveat, or question.
Ezzeddine et al. (2022) conducted a review in Ventricular arrhythmias in cardiac sarcoidosis. Catheter ablation was evaluated. Catheter ablation has evolved into an effective approach for reducing the burden of ventricular arrhythmias in patients with cardiac sarcoidosis as part of a multifaceted treatment strategy.
Synapse has enriched 10 related papers. Consider them for comparative context: